Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease

BACKGROUND: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that has a wide range of effects on glucose metabolism and cardiovascular function (e.g., improving insulin sensitivity, reduction in appetite, modulation of heart rate, blood pressure and myocardial contractility). Metabolic syndrom...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yamaoka-Tojo, Minako, Tojo, Taiki, Takahira, Naonobu, Matsunaga, Atsuhiko, Aoyama, Naoyoshi, Masuda, Takashi, Izumi, Tohru
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Original investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2891690/
https://ncbi.nlm.nih.gov/pubmed/20470376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-9-17
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki